Enveric Biosciences Inc (NAS:ENVB)
$ 0.5042 0.0032 (0.64%) Market Cap: 4.50 Mil Enterprise Value: -2.60 Mil PE Ratio: 0 PB Ratio: 0.73 GF Score: 31/100

Enveric Biosciences Inc Annual Shareholders Meeting Transcript

Oct 28, 2022 / 02:00PM GMT
Release Date Price: $3.45 (-0.58%)
Operator

Welcome to the 2022 annual meeting of stockholders of Enveric Biosciences, Inc. I would now like to introduce Joseph Tucker, the Chief Executive Officer of Enveric Biosciences, Inc.

Joseph Tucker
Enveric Biosciences, Inc. - CEO

Good morning, ladies and gentlemen. I'm Joseph Tucker, Chief Executive Officer and Member of the Board of Directors of Enveric Biosciences, Inc. I welcome you to the 2022 annual meeting of stockholders.

Let's start by introducing the directors of the company: David Johnson, Executive Chairman of the Board; George Kegler, Director; Sol Mayer, Director; Marcus Schabacker, Director; Douglas Lind, Director; Bevin O'Neil, Director; Frank Pasqualone, Director; and Michael Webb, Director.

I will conduct and act as Chairman of this meeting. Rob Dickey, our Chief Financial Officer, will act as Secretary of the meeting. I hereby call the meeting to order.

The company has appointed Anthony P. Carideo as the inspector of election. Mr. Carideo is participating in this virtual meeting and has taken and signed an oath of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot